“Your vision is better, your instruments are better, and so we can do an excellent cancer operation while maintaining really good rates of continence and potency recovery,” says David Lee, MD.
David Lee, MD, professor of Clinical Urology at UCI Health, discusses the benefits of robotic surgery in patients with prostate cancer. Lee is a robotic surgery expert who has completed more than 6300 robotic surgical procedures.
Cell-cycle risk score is predictive of ADT benefit in prostate cancer
May 17th 2024"Prolaris precisely describes the difference in metastasis outcomes for men receiving monotherapy (RT) vs multimodal therapy (RT+ADT), and further tells me precisely what the risk of death is for a man on surveillance," says Jonathan D. Tward, MD, PhD.